Clinical outcomes in patients age 40 or younger at diagnosis of synchonous metastatic colorectal cancer. Background: Drozitumab is a monoclonal antibody that triggers tumor cell apoptosis by selective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback